Mountain View, CA, United States of America

Peter Crisalli

USPTO Granted Patents = 11 

 

Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Sunnyvale, CA (US) (2020 - 2021)
  • Mountain View, CA (US) (2020 - 2023)

Company Filing History:


Years Active: 2020-2025

where 'Filed Patents' based on already Granted Patents

11 patents (USPTO):

Title: The Innovative Contributions of Peter Crisalli

Introduction

Peter Crisalli is a notable inventor based in Mountain View, CA, with a remarkable portfolio of 11 patents. His work primarily focuses on advancements in nucleic acid detection and sequencing technologies, which have significant implications in the fields of biotechnology and molecular biology.

Latest Patents

Crisalli's latest patents include groundbreaking innovations such as tagged nucleoside compounds useful for nanopore detection. This patent describes tagged nucleoside compounds that consist of a nucleotide polyphosphate covalently attached to a tag. The compound serves as a polymerase substrate, allowing the polymer moiety to enter a nanopore linked to the polymerase, thereby altering the flow of ions through the nanopore. Additionally, he has developed methods for preparing these tagged nucleoside compounds and utilizing them as tags in nanopore-based nucleic acid detection and sequencing. Another significant patent is for the purification of polymerase complexes, which outlines methods for isolating polymerase complexes from a mixture of components. These polymerase complexes can include a nanopore to facilitate isolated nanopore sequencing complexes.

Career Highlights

Throughout his career, Peter Crisalli has worked with prominent companies such as Roche Sequencing Solutions, Inc. and F. Hoffmann-La Roche AG. His contributions to these organizations have been instrumental in advancing their research and development efforts in sequencing technologies.

Collaborations

Crisalli has collaborated with talented individuals in his field, including Meng Taing and Aruna Ayer. These partnerships have fostered innovation and have led to significant advancements in their respective projects.

Conclusion

Peter Crisalli's innovative work and numerous patents reflect his dedication to enhancing nucleic acid detection and sequencing technologies. His contributions continue to influence the biotechnology landscape, showcasing the importance of innovation in scientific research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…